cardiome pharma corp
(COM:Toronto Stock Exchange)
Stanley Nattel M.D.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Dr. Stanley Nattel, M.D. serves as Director of the Paul-David Chair in cardiovascular electrophysiology at the Université de Montréal. Dr. Nattel serves as Clinical Advisor, Atrial Fibrillation of Xention Limited. He served as the Scientific Director of the Research Center of Montreal Heart Institute since 1990 until 2004. In 1987, Dr. Nattel moved to Montreal Heart Institute and the University of Montreal. He was a Cardiologist/Clinical Pharmacologist at the Montreal ...
1441 CREEKSIDE DRIVEPhone: 604-677-6905
Vancouver, British Columbia V6J 4S7
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Clive A. Meanwell M.D., Ph.D.||Chief Executive Officer and Director|
The Medicines Company
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Albert David Friesen Ph.D.||Founder, Chairman and Chief Executive Officer|
|C$105.0K||Compensation as of Fiscal Year 2014.|